Mark H. Rachesky MD - 07 May 2025 Form 4 Insider Report for STARZ ENTERTAINMENT CORP /CN/ (STRZ)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
07 May 2025, 18:51:33 UTC
Prior SEC filing
07 May 2025
Next SEC filing
13 May 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Janet Yeung as attorney in fact

Key filing fact

Mark H. Rachesky MD filed Form 4 for STARZ ENTERTAINMENT CORP /CN/ (STRZ) on 07 May 2025.

Key facts

  • This page summarizes Mark H. Rachesky MD's Form 4 filing for STARZ ENTERTAINMENT CORP /CN/ (STRZ).
  • 17 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 07 May 2025, 18:51.

Change

  • Previous filing in this sequence was filed on 07 May 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001194368 Primary reporting owner

RACHESKY MARK H MD

Relationship
Director, 10%+ Owner
Address
40 WEST 57TH STREET, FLOOR 24, NEW YORK
Signature
/s/ Janet Yeung as attorney in fact
Signature date
07 May 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

LGF transaction

Class A Voting Shares

Other

Transaction value
$0
Shares
-100,865
Change %
-100%
Price
$0.000000
Shares after
0
Date
07 May 2025
Ownership
Direct
Footnotes
F16, F17, F18
LGF transaction

Class B Non-Voting Shares

Other

Transaction value
$0
Shares
-106,191
Change %
-100%
Price
$0.000000
Shares after
0
Date
07 May 2025
Ownership
Direct
Footnotes
F16, F17, F18
LGF transaction

Class A Voting Shares

Other

Transaction value
$0
Shares
-9,102
Change %
-100%
Price
$0.000000
Shares after
0
Date
07 May 2025
Ownership
Direct
Footnotes
F1, F16, F17, F18
LGF transaction

Class B Non-Voting Shares

Other

Transaction value
$0
Shares
-10,176
Change %
-100%
Price
$0.000000
Shares after
0
Date
07 May 2025
Ownership
Direct
Footnotes
F2, F16, F17, F18
LGF transaction

Class A Voting Shares

Other

Transaction value
$0
Shares
-811
Change %
-100%
Price
$0.000000
Shares after
0
Date
07 May 2025
Ownership
Direct
Footnotes
F3, F16, F17, F18
LGF transaction

Class B Non-Voting Shares

Other

Transaction value
$0
Shares
-861
Change %
-100%
Price
$0.000000
Shares after
0
Date
07 May 2025
Ownership
Direct
Footnotes
F4, F16, F17, F18
LGF transaction

Class A Voting Shares

Other

Transaction value
$0
Shares
-1,506,086
Change %
-100%
Price
$0.000000
Shares after
0
Date
07 May 2025
Ownership
See Footnotes
Footnotes
F5, F6, F16, F17, F18
LGF transaction

Class B Non-Voting Shares

Other

Transaction value
$0
Shares
-698,383
Change %
-100%
Price
$0.000000
Shares after
0
Date
07 May 2025
Ownership
See Footnotes
Footnotes
F5, F6, F16, F17, F18
LGF transaction

Class A Voting Shares

Other

Transaction value
$0
Shares
-193,816
Change %
-100%
Price
$0.000000
Shares after
0
Date
07 May 2025
Ownership
See Footnotes
Footnotes
F7, F16, F17, F18
LGF transaction

Class B Non-Voting Shares

Other

Transaction value
$0
Shares
-93,308
Change %
-100%
Price
$0.000000
Shares after
0
Date
07 May 2025
Ownership
See Footnotes
Footnotes
F7, F16, F17, F18
LGF transaction

Class A Voting Shares

Other

Transaction value
$0
Shares
-693,137
Change %
-100%
Price
$0.000000
Shares after
0
Date
07 May 2025
Ownership
See Footnotes
Footnotes
F8, F9, F16, F17, F18
LGF transaction

Class B Non-Voting Shares

Other

Transaction value
$0
Shares
-693,137
Change %
-100%
Price
$0.000000
Shares after
0
Date
07 May 2025
Ownership
See Footnotes
Footnotes
F8, F9, F16, F17, F18
LGF transaction

Class A Voting Shares

Other

Transaction value
$0
Shares
-1,746,221
Change %
-100%
Price
$0.000000
Shares after
0
Date
07 May 2025
Ownership
See Footnotes
Footnotes
F10, F11, F16, F17, F18
LGF transaction

Class B Non-Voting Shares

Other

Transaction value
$0
Shares
-1,746,221
Change %
-100%
Price
$0.000000
Shares after
0
Date
07 May 2025
Ownership
See Footnotes
Footnotes
F10, F11, F16, F17, F18
LGF transaction

Class A Voting Shares

Other

Transaction value
$0
Shares
-11,874,473
Change %
-100%
Price
$0.000000
Shares after
0
Date
07 May 2025
Ownership
See Footnotes
Footnotes
F12, F13, F16, F17, F18
LGF transaction

Class B Non-Voting Shares

Other

Transaction value
$0
Shares
-11,874,473
Change %
-100%
Price
$0.000000
Shares after
0
Date
07 May 2025
Ownership
See Footnotes
Footnotes
F12, F13, F16, F17, F18
LGF transaction

Class A Voting Shares

Other

Transaction value
$0
Shares
-4,113,927
Change %
-100%
Price
$0.000000
Shares after
0
Date
07 May 2025
Ownership
See Footnotes
Footnotes
F14, F15, F16, F17, F18
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Mark H. Rachesky MD is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 18 footnotes

Footnote F1

Annual director compensation awards. These are restricted share units granted by the Issuer, payable upon vesting in an equal number of Class A Voting Shares, which are scheduled to vest in one annual installment on November 29, 2025.

Footnote F2

Annual director compensation awards. These are restricted share units granted by the Issuer, payable upon vesting in an equal number of Class B Non-Voting Shares, which are scheduled to vest in one annual installment on November 29, 2025.

Footnote F3

These are restricted share units granted by the Issuer, payable upon vesting in an equal number of Class A Voting Shares, which are scheduled to vest in one remaining equal annual installment on September 13, 2025.

Footnote F4

These are restricted share units granted by the Issuer, payable upon vesting in an equal number of Class B Non-Voting Shares, which are scheduled to vest in one remaining equal annual installment on September 13, 2025.

Footnote F5

These shares are held for the account of MHR Capital Partners Master Account LP, an Anguilla, British West Indies limited partnership ("Master Account"). MHR Advisors LLC, a Delaware limited liability company ("Advisors"), is the general partner of Master Account. MHRC LLC, a Delaware limited liability company ("MHRC"), is the managing member of Advisors. Mark H. Rachesky, M.D. ("Dr. Rachesky") is the managing member of MHRC. MHR Fund Management LLC ("Fund Management") has an investment management agreement with Master Account pursuant to which it has the power to vote or direct the vote and to dispose or to direct the disposition of the shares held for the account of Master Account. MHR Holdings LLC, a Delaware limited liability company ("MHR Holdings"), is the managing member of Fund Management. (Continued to footnote 6)

Footnote F6

Accordingly, Advisors, MHRC, Fund Management, MHR Holdings and Dr. Rachesky may be deemed to beneficially own the shares held for the account of Master Account. Each of Advisors, MHRC, Fund Management, MHR Holdings and Dr. Rachesky disclaims beneficial ownership of such shares except to the extent of their pecuniary interest therein.

Footnote F7

These shares are held for the account of MHR Capital Partners (100) LP, a Delaware limited partnership ("Capital Partners (100)"). Advisors is the general partner of Capital Partners (100). MHRC is the managing member of Advisors. Dr. Rachesky is the managing member of MHRC. Fund Management has an investment management agreement with Capital Partners (100) pursuant to which it has the power to vote or direct the vote and to dispose or to direct the disposition of the shares held for the account of Capital Partners (100). MHR Holdings is the managing member of Fund Management. Accordingly, Advisors, MHRC, Fund Management, MHR Holdings and Dr. Rachesky may be deemed to beneficially own the shares held for the account of Capital Partners (100). Each of Advisors, MHRC, Fund Management, MHR Holdings and Dr. Rachesky disclaims beneficial ownership of such shares except to the extent of their pecuniary interest therein.

Footnote F8

These shares are held for the account of MHR Institutional Partners II LP, a Delaware limited partnership ("Institutional Partners II"). MHR Institutional Advisors II LLC, a Delaware limited liability company ("Institutional Advisors II"), is the general partner of Institutional Partners II. MHRC II LLC, a Delaware limited liability company ("MHRC II"), is the managing member of Institutional Advisors II. Dr. Rachesky is the managing member of MHRC II. Fund Management has an investment management agreement with Institutional Partners II pursuant to which it has the power to vote or direct the vote and to dispose or to direct the disposition of the shares held for the account of Institutional Partners II. MHR Holdings is the managing member of Fund Management. (Continued to footnote 9)

Footnote F9

Accordingly, Institutional Advisors II, MHRC II, Fund Management, MHR Holdings and Dr. Rachesky may be deemed to beneficially own the shares held for the account of Institutional Partners II. Each of Institutional Advisors II, MHRC II, Fund Management, MHR Holdings and Dr. Rachesky disclaims beneficial ownership of such shares except to the extent of their pecuniary interest therein.

Footnote F10

These shares are held for the account of MHR Institutional Partners IIA LP, a Delaware limited partnership ("Institutional Partners IIA"). Institutional Advisors II is the general partner of Institutional Partners IIA. MHRC II is the managing member of Institutional Advisors II. Dr. Rachesky is the managing member of MHRC II. Fund Management has an investment management agreement with Institutional Partners IIA pursuant to which it has the power to vote or direct the vote and to dispose or to direct the disposition of the shares held for the account of Institutional Partners IIA. MHR Holdings is the managing member of Fund Management. (Continued to footnote 11)

Footnote F11

Accordingly, Institutional Advisors II, MHRC II, Fund Management, MHR Holdings and Dr. Rachesky may be deemed to beneficially own the shares held for the account of Institutional Partners IIA. Each of Institutional Advisors II, MHRC II, Fund Management, MHR Holdings and Dr. Rachesky disclaims beneficial ownership of such shares except to the extent of their pecuniary interest therein.

Footnote F12

These shares are held for the account of MHR Institutional Partners III LP, a Delaware limited partnership ("Institutional Partners III"). MHR Institutional Advisors III LLC, a Delaware limited liability company ("Institutional Advisors III"), is the general partner of Institutional Partners III. Dr. Rachesky is the managing member of Institutional Advisors III. Fund Management is an affiliate of, and has an investment management agreement with, Institutional Partners III pursuant to which it has the power to vote or direct the vote and to dispose or to direct the disposition of the shares held for the account of Institutional Partners III. MHR Holdings is the managing member of Fund Management. (Continued to footnote 13)

Footnote F13

Accordingly, Institutional Advisors III, Fund Management, MHR Holdings and Dr. Rachesky may be deemed to beneficially own the shares held for the account of Institutional Partners III. Each of Institutional Advisors III, Fund Management, MHR Holdings and Dr. Rachesky disclaims beneficial ownership of such shares except to the extent of their pecuniary interest therein.

Footnote F14

These shares are held for the account of MHR Institutional Partners IV LP, a Delaware limited partnership ("Institutional Partners IV"). MHR Institutional Advisors IV LLC, a Delaware limited liability company ("Institutional Advisors IV") is the general partner of Institutional Partners IV. Dr. Rachesky is the managing member of Institutional Advisors IV. Fund Management is an affiliate of, and has an investment management agreement with, Institutional Partners IV pursuant to which it has the power to vote or direct the vote and to dispose or to direct the disposition of the shares held for the account of Institutional Partners IV. MHR Holdings is the managing member of Fund Management. (Continued to footnote 15)

Footnote F15

Accordingly, Institutional Advisors IV, Fund Management, MHR Holdings and Dr. Rachesky may be deemed to beneficially own the shares held for the account of Institutional Partners IV. Each of Institutional Advisors IV, Fund Management, MHR Holdings and Dr. Rachesky disclaims beneficial ownership of such shares except to the extent of their pecuniary interest therein.

Footnote F16

The shares reported as owned on this Form 4 do not include the shares, which the reporting persons may be deemed to beneficially own as a result of that certain Voting and Standstill Agreement, by and among the Issuer, Liberty Global Incorporated Limited, a limited company organized under the laws of England and Wales ("Liberty"), Discovery Lightning Investments Ltd., a limited company organized under the laws of England and Wales ("Discovery" and, together with Liberty, the "Buyers"), the parent companies of the Buyers, John C. Malone, Master Account, Capital Partners (100), Institutional Partners II, Institutional Partners IIA, Institutional Partners III and Fund Management, but as to which they have no pecuniary interest.

Footnote F17

On May 6, 2025, in connection with the consummation of the transactions contemplated by the Arrangement Agreement, dated as of January 29, 2025, as amended by an amending agreement dated March 12, 2025, by and among the Issuer, Lionsgate Studios Corp. ("New Lionsgate") (f/k/a Lionsgate Studios Holding Corp.), LG Sirius Holdings ULC and Lionsgate Studios Holding Corp. (f/k/a Lionsgate Studios Corp.), each share of the Issuer's Class A voting shares and Class B non-voting shares, without par value, held by the Reporting Person were exchanged for (i) New Lionsgate common shares, without par value, pursuant to the Initial Share Exchange and Second Share Exchange (as defined in the Issuer's joint proxy statement/prospectus included in the Registration Statement on Form S-4, (Continued to footnote 18)

Footnote F18

as declared effective by the U.S. Securities and Exchange Commission on March 14, 2025 (the "Form S-4")) and (ii) common shares, without par value, of Starz Entertainment Corp. ("Starz") pursuant to the Initial Share Exchange, Second Share Exchange and Reverse Stock Split (as defined in the Form S-4).

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .